4//SEC Filing
Morosini Deborah 4
Accession 0001209191-21-070352
CIK 0001678660other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:20 PM ET
Size
15.2 KB
Accession
0001209191-21-070352
Insider Transaction Report
Form 4
Morosini Deborah
EVP, Chief of Clinical Affairs
Transactions
- Exercise/Conversion
Common Stock
2021-12-15$12.85/sh+25,735$330,695→ 29,195 total - Sale
Common Stock
2021-12-15$13.00/sh−28,751$373,763→ 444 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-12-15−3,016→ 1,307 totalExercise: $1.89Exp: 2030-03-26→ Common Stock (3,016 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2021-12-15−882→ 195,163 totalExercise: $12.85Exp: 2030-09-01→ Common Stock (882 underlying) - Exercise/Conversion
Common Stock
2021-12-15$1.89/sh+3,016$5,700→ 3,460 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-12-15−24,853→ 74,575 totalExercise: $12.85Exp: 2030-09-01→ Common Stock (24,853 underlying)
Footnotes (4)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The stock option is fully vested.
- [F3]The stock option vests as to 25% of the total shares monthly beginning on September 24, 2021, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
- [F4]The stock option vests as to 25% of the total shares monthly beginning on July 27, 2020, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
Documents
Issuer
Prelude Therapeutics Inc
CIK 0001678660
Entity typeother
Related Parties
1- filerCIK 0001824625
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 5:20 PM ET
- Size
- 15.2 KB